Heartbeam Ebitda from 2010 to 2025

BEAT Stock  USD 1.77  0.04  2.21%   
Heartbeam EBITDA yearly trend continues to be comparatively stable with very little volatility. EBITDA is likely to outpace its year average in 2025. From the period from 2010 to 2025, Heartbeam EBITDA quarterly data regression had r-value of  0.04 and coefficient of variation of  525.08. View All Fundamentals
 
EBITDA  
First Reported
2006-03-31
Previous Quarter
-5.1 M
Current Value
-4.9 M
Quarterly Volatility
9.9 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Heartbeam financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heartbeam's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.7 K, Selling And Marketing Expenses of 9.3 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.79, Dividend Yield of 0.0 or PTB Ratio of 38.9. Heartbeam financial statements analysis is a perfect complement when working with Heartbeam Valuation or Volatility modules.
  
Build AI portfolio with Heartbeam Stock
Check out the analysis of Heartbeam Correlation against competitors.
For more information on how to buy Heartbeam Stock please use our How to Invest in Heartbeam guide.

Latest Heartbeam's Ebitda Growth Pattern

Below is the plot of the Ebitda of Heartbeam over the last few years. It is Heartbeam's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heartbeam's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Very volatile
   Ebitda   
       Timeline  

Heartbeam Ebitda Regression Statistics

Arithmetic Mean6,045,066
Geometric Mean8,919,726
Coefficient Of Variation525.08
Mean Deviation22,396,959
Median444,000
Standard Deviation31,741,225
Sample Variance1007.5T
Range141.1M
R-Value0.04
Mean Square Error1078.1T
R-Squared0
Significance0.90
Slope236,932
Total Sum of Squares15112.6T

Heartbeam Ebitda History

2025-18.5 M
2024-19.4 M
2023675 K
2022-12.9 M
2021-2.3 M
2020-788 K
201942.7 M

About Heartbeam Financial Statements

Heartbeam shareholders use historical fundamental indicators, such as Ebitda, to determine how well the company is positioned to perform in the future. Although Heartbeam investors may analyze each financial statement separately, they are all interrelated. The changes in Heartbeam's assets and liabilities, for example, are also reflected in the revenues and expenses on on Heartbeam's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
EBITDA-19.4 M-18.5 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Heartbeam Stock Analysis

When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.